DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Marlborough, MA

3 verified pulmonary disease doctors in Marlborough.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Massachusetts Board of Registration in Medicine

Dr. Clifford Risk, MD

Pulmonary Disease

20 yrs NPPES
NPI 1013029651
320 BOLTON ST, SUITE 101, Marlborough, MA 01752(508) 481-4288
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,669 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,669

Total received

82

Transactions

6

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$1,308
Amgen Inc.$168.97
GlaxoSmithKline, LLC.$74.64
Electromed, Inc.$56.74
Mylan Specialty L.P.$45.61
IDORSIA PHARMACEUTICALS US INC$14.65

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Clifford Risk do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kimberly Robinson, MD

Pulmonary Disease

20 yrs NPPES
NPI 1801990056
159 UNION ST, SUITE 102, Marlborough, MA 01752(508) 486-5733
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $223.71 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$223.71

Total received

10

Transactions

6

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$95.39
Boehringer Ingelheim Pharmaceuticals, Inc.$46.01
GlaxoSmithKline, LLC.$26.39
Amgen Inc.$21.22
United Therapeutics Corporation$18.04
NOVARTIS PHARMACEUTICALS CORPORATION$16.66

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 66th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kimberly Robinson do not imply any wrongdoing. Many are meals, education, or research support.

Dr. July Lau-Deza, MD

Pulmonary Disease

18 yrs NPPES
NPI 1669639811
159 UNION ST STE 102, Marlborough, MA 01752(508) 486-5733
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $349.70 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$349.70

Total received

13

Transactions

8

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$103.43
Seagen Inc.$89.88
Circassia Inc.$36.34
Bayer HealthCare Pharmaceuticals Inc.$29.96
Regeneron Healthcare Solutions, Inc.$25.98
E.R. Squibb & Sons, L.L.C.$24.98

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to July Lau-Deza do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Marlborough, MA — Verified | DoctorsProof | DoctorsProof